Silvia Valtueña Martínez

ORCID: 0009-0008-2548-0983
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Agricultural safety and regulations
  • Consumer Attitudes and Food Labeling
  • Vitamin K Research Studies
  • Food Allergy and Anaphylaxis Research
  • Nutritional Studies and Diet
  • Effects and risks of endocrine disrupting chemicals
  • Sodium Intake and Health
  • Antioxidant Activity and Oxidative Stress
  • Vitamin C and Antioxidants Research
  • Diet and metabolism studies
  • Diet, Metabolism, and Disease
  • Pharmaceutical studies and practices
  • Eosinophilic Esophagitis
  • Vitamin D Research Studies
  • Food Waste Reduction and Sustainability
  • Seaweed-derived Bioactive Compounds
  • Coffee research and impacts
  • Environmental Chemistry and Analysis
  • Muscle metabolism and nutrition
  • Retinoids in leukemia and cellular processes
  • Skin Protection and Aging
  • Sesquiterpenes and Asteraceae Studies
  • Steroid Chemistry and Biochemistry
  • Occupational exposure and asthma
  • Agriculture, Plant Science, Crop Management

European Food Safety Authority
2013-2023

Higher University of San Andrés
2011

EFSA requested the Scientific Committee to develop a guidance document on use of weight evidence approach in scientific assessments for all areas under EFSA's remit.The addresses approaches using both qualitative and quantitative approaches.Several case studies covering various remit are annexed illustrate applicability proposed approach.Weight assessment is defined this as process which integrated determine relative support possible answers question.This considers comprising three basic...

10.2903/j.efsa.2017.4971 article EN cc-by-nd EFSA Journal 2017-08-01

Following a request from the European Commission, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) derived dietary reference values (DRVs) for sodium. Evidence balance studies sodium relationship between intake health outcomes, in particular cardiovascular disease (CVD)-related endpoints bone health, was reviewed. The data were not sufficient to enable an average requirement (AR) or population (PRI) be derived. However, by integrating available evidence associated uncertainties,...

10.2903/j.efsa.2019.5778 article EN cc-by-nd EFSA Journal 2019-09-01

EFSA JournalVolume 20, Issue 2 e07074 Scientific OpinionOpen Access Tolerable upper intake level for dietary sugars Panel on Nutrition, Novel Foods and Food Allergens (NDA), Corresponding Author (NDA) nda@efsa.europa.eu Correspondence:nda@efsa.europa.euSearch more papers by this authorDominique Turck, Dominique TurckSearch authorTorsten Bohn, Torsten BohnSearch authorJacqueline Castenmiller, Jacqueline CastenmillerSearch authorStefaan de Henauw, Stefaan HenauwSearch authorKaren Ildico...

10.2903/j.efsa.2022.7074 article EN EFSA Journal 2022-02-01

EFSA asked the Panel on Dietetic Products, Nutrition and Allergies (NDA) to update guidance scientific requirements for health claims related antioxidants, oxidative damage cardiovascular published in 2011. The takes into accounts experiences gained with evaluation of additional claim applications health, information collected from a Grant launched 2014. This is intended assist applicants preparing authorisation health. document was subject public consultation (from 12 July 3 September...

10.2903/j.efsa.2018.5136 article EN cc-by-nd EFSA Journal 2018-01-01

Following two requests from the European Commission (EC), EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver a scientific opinion revision of tolerable upper intake level (UL) for vitamin D propose conversion factor (CF) calcidiol monohydrate into

10.2903/j.efsa.2023.8145 article EN cc-by-nd EFSA Journal 2023-08-01

Abstract The European Commission requested EFSA to update the scientific guidance for preparation of applications authorisation novel foods, previously developed following adoption Regulation (EU) 2015/2283 on foods. This document provides advice information needed be submitted by applicant towards demonstrating safety food. Requirements pertain description food, production process, compositional data, specifications, proposed uses and use levels anticipated intake Furthermore, in sections...

10.2903/j.efsa.2024.8961 article EN cc-by-nd EFSA Journal 2024-09-01

Abstract Following two requests from the European Commission, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver a scientific opinion revision of tolerable upper intake level (UL) for preformed vitamin A β‐carotene. Systematic reviews literature were conducted priority adverse health effects excess intake, namely teratogenicity, hepatotoxicity endpoints related bone health. Available data did not allow address whether β‐carotene could potentiate toxicity....

10.2903/j.efsa.2024.8814 article EN cc-by-nd EFSA Journal 2024-06-01

EFSA asked the Panel on Dietetic Products, Nutrition and Allergies (NDA) to update scientific technical guidance for preparation presentation of an application authorisation a health claim published in 2011. Since then, NDA has gained considerable experience evaluation claims. Lessons learnt from these experiences have been translated into new General stakeholders applications (published January 2016). In this context, it is noted need adapt existing developments area. This document presents...

10.2903/j.efsa.2017.4680 article EN cc-by-nd EFSA Journal 2017-01-01

Abstract The Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver a scientific opinion the safety of monacolins from red yeast rice (RYR), which have been placed under Union scrutiny in Part C Annex III accordance with Article 8(4) Regulation (EC) No 1925/2006. NDA reviewed additional data submitted during period scrutiny, included analytical composition RYR supplements, intake other dietary sources, vitro bioaccessibility cytotoxicity vs. statins,...

10.2903/j.efsa.2025.9276 article EN cc-by-nd EFSA Journal 2025-02-01

Abstract Following the adoption of Regulation (EU) No 1169/2011 on food information to consumers, European Commission requested EFSA update its ‘Guidance safety evaluation sources nutrients and bioavailability nutrient from sources’ regarding scientific principles data requirements for assessment all new forms micronutrients derive a conversion factor micronutrient or be authorised addition foods, including supplements. This guidance outlines that NDA Panel will consider quantification...

10.2903/j.efsa.2024.8946 article EN cc-by-nd EFSA Journal 2024-09-01

Following a request from the European Commission, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver scientific opinion safety suitability for use by infants of follow-on formulae (FOF) based cow's milk intact protein with content at least 1.6 g/100 kcal (rounded value) that meet otherwise requirements relevant EU legislation. If formula under evaluation is considered be safe suitable infants, NDA also advise whether FOF goat's protein, soy isolates or...

10.2903/j.efsa.2017.4781 article EN cc-by-nd EFSA Journal 2017-05-01

EFSA was asked by the European Commission to provide scientific assistance with respect adopted opinion on ‘Safety of calcidiol monohydrate produced chemical synthesis as a novel food pursuant Regulation (EU) 2015/2283’, including its bioavailability metabolite vitamin D3 when added for nutritional purposes supplements. On 5 July 2023, ‘Scientific tolerable upper intake level D, derivation conversion factor monohydrate’. This concerns an updated exposure assessment D and proposes into 2.5...

10.2903/j.efsa.2024.8520 article EN cc-by-nd EFSA Journal 2024-01-01

EFSA has asked the Panel on Nutrition, Novel Foods and Food Allergens (NDA) to update guidance scientific requirements for health claims related physical performance published in 2012. The takes into account experience gained by NDA with evaluation of additional claim applications, changes introduced general stakeholders applications information collected from a grant launched 2014 which aimed at gathering relation claimed effects, outcome variables methods measurement context substantiation...

10.2903/j.efsa.2018.5434 article EN cc-by-nd EFSA Journal 2018-10-01

Following a request from the European Commission, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide scientific technical guidance for preparation presentation of applications authorisation infant and/or follow-on formula manufactured protein hydrolysates. This document addresses information data be submitted formulae hydrolysates with respect safety suitability specific formula's efficacy in reducing risk developing allergy milk proteins. The will further...

10.2903/j.efsa.2017.4779 article EN cc-by-nd EFSA Journal 2017-05-01

Abstract Following a request from the European Commission, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion safety of extension use oil Schizochytrium limacinum (strain FCC‐3204) as novel food (NF) pursuant Regulation (EU) 2015/2283. The pertains NF ingredient in protein products at maximum level 1 g docosahexaenoic acid (DHA) 100 product. considers that information provided composition production process is sufficiently described does not raise...

10.2903/j.efsa.2024.9043 article EN cc-by-nd EFSA Journal 2024-10-01

Abstract Vitamins and essential minerals are micronutrients that required for the normal functioning of human body. However, they may lead to adverse health effects if consumed in excess. A tolerable upper intake level (UL) is a science‐based reference value supports policy‐makers other relevant actors managing risks excess nutrient intake. EFSA's principles establishing ULs vitamins were originally developed by Scientific Committee on Food 2000. This guidance from EFSA Panel Nutrition,...

10.2903/j.efsa.2024.9052 article EN cc-by-nd EFSA Journal 2024-11-01

In 2014, the European Food Safety Authority (EFSA) started PROMETHEUS (PROmoting METHods for Evidence Use in Scientific assessments) project to improve further and increase consistency of methods it uses its scientific assessments. The defined a set principles assessment process 4-step approach (plan/carry out/verify/report) their fulfilment, which was tested ten case studies, one from each EFSA panel. present report describes benefits, issues, needs solutions related implementation EFSA,...

10.2903/sp.efsa.2018.en-1395 article EN other-oa EFSA Supporting Publications 2018-04-01

Following a request from the European Commission, EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) was requested to deliver scientific opinion safety assessment of flavouring substances caffeine [FL-no: 16.016] theobromine 16.032] in Flavouring Group Evaluation 49, Revision 1. Consequent 2015 Dietetic Products, Nutrition Allergies (NDA) all dietary sources, CEF considered it inappropriate evaluate two through Procedure. For caffeine, based its threshold...

10.2903/j.efsa.2017.4729 article EN cc-by-nd EFSA Journal 2017-04-01

Abstract This Scientific Report was carried out in the context of self‐task mandate (M‐2023‐00097) EFSA's Committee on ‘Guidance use biomarkers effect regulatory risk assessment chemicals’. In first phase, project started with a feasibility study (EFSA‐Q‐2024‐00128), intention to look closer at definitions and descriptions effect, as well explore several concepts related application other scientific principles be further considered for its development. addition, relevant activities,...

10.2903/j.efsa.2024.9153 article EN cc-by-nd EFSA Journal 2024-12-01
Coming Soon ...